Gleamer

Gleamer featured on national French TV on TF1! 🇫🇷 Groupe TF1 We’re proud to see Gleamer highlighted on Groupe TF1, showcasing how AI is transforming healthcare and supporting radiologists in their daily practice. 👉 Watch the replay: https://lnkd.in/eFTWfScv

🩻 Case of the Month - BoneCT A lesion can easily be missed, with significant consequences. In this month’s case, we highlight a staging CT of an 85-year-old patient with melanoma. A single bone metastasis was hiding at the very bottom of the scan, an area where attention naturally drops and errors are more likely. BoneCT, our AI for detecting secondary bone lesions, flagged this subtle finding, one that could have easily been missed, yet carries major clinical impact. Because in oncology, detecting even one metastasis can change the course of patient management. 👉 Book your BoneCT demo now: https://lnkd.in/emxhB79s

We’re very excited to announce that Gleamer is once again present at ECR, Europe’s leading radiology congress. 📍 Visit us at Booth 09 in the AI Hall to meet the team, discover our latest products and news, and experience Voice live. We also invite you to stop by Booth 506, Hall X5 to meet our colleagues from DeepHealth, as we’re now one team. 🤝 Looking forward to seeing many of you there!

🚀 Today marks an important milestone for Gleamer. We are excited to announce that we will be joining DeepHealth. Today, RadNet, a national leader in outpatient diagnostic imaging services, announced it has acquired Gleamer to be integrated into DeepHealth, its wholly owned subsidiary and a global leader in AI-powered health informatics. With the integration, we are creating the largest provider of radiology clinical AI solutions worldwide. “Joining DeepHealth marks an exciting new chapter for our business and team members,” said Christian Allouche, Co-Founder and CEO of Gleamer. “Our team has been driven by a mission to improve patient care and access, and we are proud of the impact we have had on our customers and patients worldwide. By combining our AI capabilities, product portfolio and strong commercial team with that of DeepHealth, we are poised to shape the future of intelligent imaging at scale.” Since 2017, our mission has been to improve quality of care while reducing the radiologist workload with clinically validated radiology AI and workflow solutions. With more than 700 customer contracts across 44 countries, and a wide portfolio of four FDA-cleared and six CE-marked devices supporting 25+ indications spanning X-ray, Mammography, CT and MRI, our team has worked relentlessly to bring high-impact innovation and advance routine imaging and high-impact acute care. This next chapter enables us to accelerate our impact, scale our technology globally, and continue advancing more standardized interpretation, automated prioritization and draft reporting, and scalable diagnostic pathways. We are proud of what we have achieved, and excited for what we will build together! Learn more: https://lnkd.in/dfwy8vFd

🤝 Partnership announcement. We’re very proud to announce our new partnership with Affidea 🎉, one of Europe’s leading providers of advanced diagnostic imaging and outpatient services. Through this collaboration, Affidea has decided to partner with Gleamer to deploy our AI-powered radiology solutions across Affidea’s network, helping radiologists enhance diagnostic accuracy, improve workflow efficiency, and deliver even better care to patients. This partnership marks a major step forward in our shared mission to revolutionize medical imaging with AI.

🎯 BoneView For Orthopaedic Surgeons Two new clinical studies from the CHU Amiens-Picardie and Universitätsklinikum Brandenburg an der Havel were published concomitantly, each independently confirming the high diagnostic performance of BoneView for hand trauma. These retrospective studies measure the performance of AI in orthopedic care, specifically in the detection of distal radius fractures (DRFs), comparing BoneView to resident and experienced orthopaedic surgeons. 💡 Key findings: - BoneView had the highest sensitivity (97.6% vs. 92.8%) - Showed comparable performance to an experienced orthopaedic surgeon on both AP and lateral views as a reliable support for clinical decision-making - BoneView demonstrated high NPV at 99.2% These findings confirm that BoneView performs on par with human experts. BoneView could assist orthopedic teams in emergency and trauma, especially where radiologist resources are limited, and may significantly enhance diagnostic efficiency by decreasing radiologists' workloads and producing accurate, timely evaluations. 🇫🇷 Publication from CHU Amiens-Picardie Title: Artificial intelligence and human expertise in hand trauma diagnosis: A collaborative approach Journal: Orthopaedics & Traumatology: Surgery & Research 👉 Read the full article: https://lnkd.in/eryxdugg 👏 Congratulations to the authors from CHU Amiens Picardie Céline Klein, Pierre Fondu, Daniel Aiham Ghazali, Vladimir Rotari, Osama Abou-Arab & Emmanuel David 🇩🇪 Publication from Universitätsklinikum Brandenburg an der Havel Title: Artificial intelligence-guided distal radius fracture detection on plain radiographs in comparison with human raters Journal: Journal of Orthopaedic Surgery and Research 👉 Read the full article: https://lnkd.in/eXWetB6G 👏 Congratulations to the authors from Universitätsklinikum Brandenburg an der Havel Nikolai Ramadanov, Patric John, Robert Hable, Andreas Georg Schreyer, Simon Shabo, Robert Prill & Mikhail Salzmann ✨ Learn more on how BoneView, our CE-certified and FDA-cleared solution, could support orthopaedic trauma care: https://lnkd.in/eVsh2P-6 #Radiology #AIinHealthcare #OrthopaedicTrauma

🎗 Every cancer is unique. Every patient is too. This #WorldCancerDay, we stand with the millions impacted by cancer, patients, caregivers, and the medical teams fighting by their side. At Gleamer, we're proud to support radiologists with our tools, including our oncology AI solutions like BoneCT, LungCT and BreastView, helping detect cancer with greater confidence. 💡 AI doesn’t replace clinical judgment, it amplifies it, especially when every second counts. Let’s keep pushing to detect sooner, treat smarter, and care better.

🇺🇸 Across the US, radiologists face growing workloads and increasing diagnostic pressure, especially in emergency settings. BoneView, our US FDA-cleared AI-powered solution for bone trauma, is designed to support clinicians by highlighting fractures and critical findings on X-rays. Our goal is to help radiologists read faster, with confidence, while staying fully in control of the final diagnosis. Avishkar (Avi) Sharma, MD, CIIP, Director of AI and Body Radiologist at Jefferson Health, shares his experience using BoneView: 💬 “Operationally, BoneView acts as a quality-assurance layer that reduces the likelihood of missed fractures, which supports both patient safety and workflow efficiency. By helping triage cases more effectively and reducing callbacks or repeat imaging, it saves radiologist time and decreases overall friction in the emergency and outpatient settings.” 🙏 A big thanks to Avishkar (Avi) Sharma, MD, CIIP for his trust and confidence in our solutions. 🇺🇸 Trusted by radiologists across the United States. 👉 Learn more about our US FDA-cleared solution BoneView here: https://lnkd.in/eQys4gis

🏆 2025 has been a year of growth, and last week, we took the time to reflect on it together. Each year, our worldwide teams gather in Paris for the Gleamer Days. This edition was particularly special, as we had the chance to come together in the heart of the Eiffel Tower! 🇫🇷 This Gleamer Day brought together all our colleagues to look back on the progress we’ve made, celebrate the key milestones, and the collective effort driving our growth. 🚀 It was also a key moment to look ahead to 2026: the day was shaped by strong alignment on our ambitions, thoughtful discussions on sustainable growth, and inspiring talks from our founders on Gleamer’s long-term vision. Beyond strategy and performance, it was above all a moment of deep connection and shared discussions. ✨ A very positive day, and a strong reminder that meaningful innovation starts with people working together, a big thank you and congratulations to all of our Gleamer teams!

🇺🇸 We’re proud to see Gleamer’s AI solutions supporting radiologists across the United States and we’re pleased to share a testimonial from one of our trusted physicians, Brett Oliver, MD, from Baptist Health System KY & IN. 💬 “Since introducing this technology, we’ve significantly improved patient throughput. While traditional X-ray methods have long supported quality care, Gleamer BoneView US has helped enhance both efficiency and accuracy. This aligns with our commitment to delivering patient-centered care that is timely and precise.” Dr. Oliver further explains the impact BoneView US has had on night shifts and demanding workflows: “Both radiologists and ED physicians are very confident in the reads they receive from BoneView US which has helped us with patient throughput when overnight reads can be delayed for plain films. This has allowed our ED physicians to provide a disposition to their patients quicker.” Their commitment to high-quality patient care inspires us as we continue developing AI tools that truly support clinical workflows and radiologists, not replace them. 🙏 A special thanks to Brett Oliver, MD for sharing his experience with BoneView. 👉 Learn more about our US FDA-cleared solution BoneView here: https://lnkd.in/eQys4gis